Enoxaparin, a low-molecular-weight heparin suppresses prothrombin activation more effectively than unfractionated heparin in patients treated for venous thromboembolism.

A. Grosset,T. Spiro,J. Beynon,G. Rodgers
DOI: https://doi.org/10.1016/S0049-3848(97)00079-0
IF: 10.407
1997-06-01
Thrombosis Research
Abstract:
What problem does this paper attempt to address?